Ganciclovir is the drug of choice for fighting the cytomegalovirus that causes CMV retinitis. It is typically recommended that the patient take two 10 mg doses for one week, then 5 milligrams once a day for 100 days. If the condition is considered to be severe, the drug may be given intravenously.
A study at the Wilmer Eye Institute at Johns Hopkins on treating CMV retinitis also indicates that a combination of ganciclovir and another antiviral drug (called foscarnet) is a more effective way to treat repeat episodes of this potentially blinding infection than with either drug alone.
A study at the Wilmer Eye Institute at Johns Hopkins on treating CMV retinitis also indicates that a combination of ganciclovir and another antiviral drug (called foscarnet) is a more effective way to treat repeat episodes of this potentially blinding infection than with either drug alone.
